Assignee
THERATECHNOLOGIES INC
CA21 patents
Top patents by PatentIndex Score
US6106544AAug 22, 2000
Cutaneous harness for sutureless wound closing
THERATECHNOLOGIES INC114 citations97
US5843123ADec 1, 1998
Cutaneous harness for sutureless wound closing
THERATECHNOLOGIES INC74 citations96
US5834418ANov 10, 1998
Process for the preparation of platelet growth factors extract
THERATECHNOLOGIES INC139 citations95
US5602924AFeb 11, 1997
Electronic stethescope
THERATECHNOLOGIES INC1,169 citations93
US6458764B1Oct 1, 2002
GRF analogs with increased biological potency
THERATECHNOLOGIES INC29 citations92
US6194384B1Feb 27, 2001
Long-acting galenical formulation for GRF peptides
THERATECHNOLOGIES INC22 citations92
US6020311AFeb 1, 2000
GRF analogs with increased biological potency
THERATECHNOLOGIES INC32 citations92
US5939386AAug 17, 1999
Chimeric fatty body-pro-GRF (1-29) analogs with increased biological potency
THERATECHNOLOGIES INC33 citations91
US5861379AJan 19, 1999
Chimeric fatty body-pro-GRF analogs with increased biological potency
THERATECHNOLOGIES INC35 citations91
US7316997B2Jan 8, 2008
GH secretagogues and uses thereof
THERATECHNOLOGIES INC21 citations90
US5798523AAug 25, 1998
Irradiating apparatus using a scanning light source for photodynamic treatment
THERATECHNOLOGIES INC29 citations83
US6864239B2Mar 8, 2005
Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
THERATECHNOLOGIES INC14 citations81
US7893025B2Feb 22, 2011
Use of growth hormone releasing factor analogs in treating patients suffering from wasting
THERATECHNOLOGIES INC14 citations79
US7094761B2Aug 22, 2006
Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
THERATECHNOLOGIES INC10 citations71
US8361964B2Jan 29, 2013
Growth hormone releasing factor (GRF) analogs and uses thereof
THERATECHNOLOGIES INC3 citations61
US7067488B2Jun 27, 2006
Modified GLP-1 peptides with increased biological potency
THERATECHNOLOGIES INC5 citations60
US7414029B2Aug 19, 2008
Antagonistic peptides of prostaglandin E2 receptor subtype EP4
THERATECHNOLOGIES INC3 citations56
US5817627AOct 6, 1998
Long-acting galenical formulation for GRF peptides
THERATECHNOLOGIES INC1 citations51
US9334314B2May 10, 2016
Peptide compounds derived from melanotransferrin and uses thereof
THERATECHNOLOGIES INC0 citations47
US8871713B2Oct 28, 2014
Formulations of growth hormone releasing factor (GRF) molecules with improved stability
THERATECHNOLOGIES INC0 citations41
US7538185B2May 26, 2009
Glucagon-like peptide-1 analogs with long duration of action
THERATECHNOLOGIES INC0 citations37